Gossamer Bio reported a quarterly loss of $0.20 per share, missing the Zacks Consensus Estimate for a $0.17 loss and widening from a $0.16 loss a year ago. The result is a modest negative versus expectations, but the article provides no revenue or guidance details. The news is likely to have limited stock impact beyond the earnings miss.
Gossamer Bio reported a quarterly loss of $0.20 per share, missing the Zacks Consensus Estimate for a $0.17 loss and widening from a $0.16 loss a year ago. The result is a modest negative versus expectations, but the article provides no revenue or guidance details. The news is likely to have limited stock impact beyond the earnings miss.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.22
Ticker Sentiment
